Visionary Holdings (Nasdaq: GV) Announces a Breakthrough Strategic Alliance With Yike Regenerative Medicine to Unlock the Trillion-Dollar Cellular Rejuvenation and Aesthetic Treatment MarketNEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (
NASDAQ:GV) ("GV" or the "Company"), a technology-driven multinational enterprise, today announced that it has entered into a strategic partnership with Jiangsu Yike Regenerative Medicine. ("Yike "), a leading regenerative medical research institute in China. The two parties will combine their respective strengths to collaborate on research, development, and commercialization in the fields of cellular rejuvenation and aesthetic treatment.
Stocks Under $3 for March 2025: PNPN.V, GV, KITT, TRNR, PRSO, Lead the ChargeAs investors hunt for high-potential stocks under $3, several companies are making headlines with major funding, strategic acquisitions, and groundbreaking innovations . From critical minerals and clean energy to AI-driven robotics and fitness technology , these emerging players are gaining traction and poised for significant growth .
